SpliceBio raised $135m in Series B co-led by EQT and Sanofi, w/ Roche Venture Fund, NEA, UCB Ventures, Ysios Capital, Gilde Healthcare, Novartis and Asabys. Biotech Health services Investments 01 June 2025 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 135M Round investors: EQT PartnersYsios CapitalAsabys PartnersGilde HealthcareRoche Venture FundUCB VenturesSanofi VenturesNew Enterprise AssociatesNovartis Venture Fund Company: Splice Bio Industry: BiotechHealth services
AAVantgarde Bio to raise $141M series B co-led by Schroders Capital with existing investors Atlas Venture and Forbion Biotech Health services Investments 19 October 2025
Hemab raised $157m Series C led by Sofinnova, joined by Avoro Capital, RA Capital, Novo, Access Biotechnology, Deep Track, HealthCap, Invus, Maj Invest Biotech Health services Investments 16 October 2025
ImCheck Therapeutics to be acquired by pharmaceutical company Ipsen for a total potential consideration up to €1 billion Biotech Health services Pharma M&A 12 October 2025
Tubulis raised €308 million in a Series C funding round co-led by Venrock, Wellington Management, and Ascenta Capital, Biotech Health services Investments 03 October 2025
Onum in Spain was acquired by US-based CrowdStrike for $290 million. AI (big data) Competitive Intelligence Software Services M&A 10 August 2025